Literature DB >> 28993856

[Malignant lymphomas of the eye].

F Fend1, D Süsskind2, C Deuter2, S E Coupland3.   

Abstract

The eye and the ocular adnexae are rare sites for malignant non-Hodgkin lymphoma (NHL). Based on their anatomical location, intraocular lymphomas must be discerned from NHL of adnexal structures including conjunctiva, lacrimal gland, and orbit. Whereas the latter group mostly consists of indolent extranodal marginal zone B‑cell lymphomas of mucosa-associated lymphoid tissue (MALT) type or secondary manifestations of systemic NHL, most primary intraocular lymphomas are classified as diffuse large B‑cell lymphomas (DLBCL) and are considered a variant of primary DLBCL of the central nervous system. The most common form is primary vitreoretinal lymphoma (PVRL), which presents with nonspecific symptoms and is difficult to discern from uveitis. Diagnosis of PVRL is usually made by cytological, immunocytochemical, and molecular analysis of vitreous aspirates. Degenerative changes, limited material, and the occurrence of pseudoclonality in the molecular analysis of B‑cell clonality can hamper diagnostic assessment. Novel techniques such as detection of MYD88 mutations common in PVRL can increase diagnostic sensitivity. Close cooperation with clinical colleagues and rapid specimen processing are fundamental for successful diagnosis.

Entities:  

Keywords:  B-cell lymphoma; Lymphoma, vitreoretinal; Marginal zone lymphoma; Masquerade syndrome; Non-Hodgkin lymphoma

Mesh:

Year:  2017        PMID: 28993856     DOI: 10.1007/s00292-017-0378-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  23 in total

1.  A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.

Authors:  Sophie Camilleri-Broët; Emmanuelle Crinière; Philippe Broët; Vincent Delwail; Karima Mokhtari; Anne Moreau; Michèle Kujas; Martine Raphaël; Wafae Iraqi; Catherine Sautès-Fridman; Philippe Colombat; Khê Hoang-Xuan; Antoine Martin
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 2.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

Review 3.  Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment.

Authors:  Marianna Sassone; Maurilio Ponzoni; Andrés J M Ferreri
Journal:  Best Pract Res Clin Haematol       Date:  2016-12-07       Impact factor: 3.020

4.  Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.

Authors:  Sarah E Coupland; Michael Hummel; Hans-Henning Müller; Harald Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

Review 5.  Primary intraocular lymphoma of T-cell type: report of a case and review of the literature.

Authors:  Sarah E Coupland; Gerasimos Anastassiou; Norbert Bornfeld; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

Review 6.  [Lymphoma of the ocular adnexa].

Authors:  V Kakkassery; N Stübiger; I A Adamietz; I Tischoff; A Baraniskin; I M Wunderlich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

7.  Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

Authors:  S A Riemersma; E S Jordanova; R F Schop; K Philippo; L H Looijenga; E Schuuring; P M Kluin
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

8.  Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.

Authors:  Alberto Gonzalez-Aguilar; Ahmed Idbaih; Blandine Boisselier; Naïma Habbita; Marta Rossetto; Alice Laurenge; Aurélie Bruno; Anne Jouvet; Marc Polivka; Clovis Adam; Dominique Figarella-Branger; Catherine Miquel; Anne Vital; Hervé Ghesquières; Rémy Gressin; Vincent Delwail; Luc Taillandier; Olivier Chinot; Pierre Soubeyran; Emmanuel Gyan; Sylvain Choquet; Caroline Houillier; Carole Soussain; Marie-Laure Tanguy; Yannick Marie; Karima Mokhtari; Khê Hoang-Xuan
Journal:  Clin Cancer Res       Date:  2012-07-26       Impact factor: 12.531

9.  Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.

Authors:  Steve Daniel Levasseur; Leah Arin Wittenberg; Valerie Ann White
Journal:  JAMA Ophthalmol       Date:  2013-01       Impact factor: 7.389

10.  Biological diagnosis of primary intraocular lymphoma.

Authors:  Hélène Merle-Béral; Frédéric Davi; Nathalie Cassoux; Sylvie Baudet; Chantal Colin; Thomas Gourdet; Bahram Bodaghi; Phuc LeHoang
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

View more
  2 in total

1.  [Retinal manifestation in hematological diseases].

Authors:  M Rehak; N Feltgen; P Meier; P Wiedemann
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

2.  Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma.

Authors:  Gábor Gy Deák; Debra A Goldstein; Mei Zhou; Amani A Fawzi; Lee M Jampol
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.